Virus Filtration Market Scope
Virus filtration retains virus particles with the use of a membrane barrier. It is a size-based removal method that uses a precisely designed polymeric membrane to retain virus particles on the surface and within the pores of the membrane. Virus-filtration systems are also used in biopharmaceutical manufacturing to assure the safety and viability of the drugs created by removing potential impurities from products that are developed through cell cultures.
Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Virus Filtration market throughout the predicted period.
Pall Corporation (United States), Sartorius Corporate Administration GmbH (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (United States), Charles River Laboratories International, Inc. (United States), GE Healthcare (United States), Asahi Kasei Medical Co., Ltd. (Japan), WuXi PharmaTech (China), Lonza Group Ltd. (Switzerland), Clean Cells (France) and PendoTech (United States) are some of the key players that are part of study coverage.
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Segmentation Overview
The study have segmented the market of Global Virus Filtration market by Type (Filtration System, Kits & Reagents and Others), by Application (Air Purification, Water Purification, Medical Devices, Biologics and Others) and Region with country level break-up.
On the basis of geography, the market of Virus Filtration has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On December 5, 2019 - Sartorius, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries.
Market Trend
- Rising R&D Spending in Manufacturing Large Molecules, Biologics, and Novel Drugs
- Increasing Use of Advanced Filters
Market Drivers
- Growth in the Biopharmaceutical Industry
- Rising Incidences of Diabetes and Kidney Failure
- Growing Demand for Biopharmaceutical Molecules
Opportunities
- Increasing Purity Requirements by End Users in Developing Economies
- Growth in the Adoption of Single-Use Devices & Disposables
Restraints
- Stringent Government Regulations for Validation of Filtration Processes
Challenges
- Intense Competition Acts as an Entry Barrier for New Entrants
- Huge Capital Expenditure Required to Set Up New Production Facilities
Key Target Audience
Manufacturers of Virus Filtration, Suppliers of Virus Filtration, Wholesalers, Distributors and Retailers of Virus Filtration, Pharmaceuticals Companies, Biotechnology Companies and Research Organization